Showing results (401-410 of 423) with videos related to

Sort By:
Pageof 43
Epilepsia|May 9, 2017
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from GermanyIsabel Steinig, Felix von Podewils, Gabriel Möddel, et al.
Archives of Virology|January 22, 2019
Genomic sequencing of a virus representing a novel type within the species Dyopipapillomavirus 1 in an Indian River Lagoon bottlenose dolphinGalaxia Cortés-Hinojosa, Kuttichantran Subramaniam, James F X Wellehan, et al.
Epilepsia|January 15, 2014
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation studyKatja Menzler, Anke Hermsen, Katharina Balkenhol, et al.
Critical Care Medicine|August 28, 2023
The Long-Term Use of Diagnostic Subdural Electroencephalogram Electrodes and Subdural Hematoma: A Prospective Cohort StudySae-Yeon Won, Thomas M Freiman, Sara Sujin Lee-Müller, et al.
Epilepsia Open|March 10, 2023
The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testingSophie von Brauchitsch, Denise Haslinger, Silvia Lindlar, et al.
Seizure|February 9, 2020
Predicting outcome of epilepsy surgery in clinical practice: Prediction models vs. clinical acumenAnne Katharina Fassin, Susanne Knake, Adam Strzelczyk, et al.
Genome Announcements|April 28, 2018
Complete Genome Sequencing of a Novel Type of Omikronpapillomavirus 1 in Indian River Lagoon Bottlenose Dolphins (Tursiops truncatus)Thaís C S Rodrigues, Kuttichantran Subramaniam, Galaxia Cortés-Hinojosa, et al.
Epilepsia|June 27, 2018
Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticusAdam Strzelczyk, Lara Kay, Sebastian Bauer, et al.
Frontiers in Neurology|August 8, 2018
Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From GermanyLaurent M Willems, Astrid Bertsche, Frank Bösebeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Pageof 43